Devonian Health Group Inc (
TSX: V.GSD,
Forum) announced Wednesday that it has received a Notice of Allowance on its patent for its anti-aging
Purgenesis treatment by the Canadian Intellectual Property Office. The compositions boast anti-wrinkle and anti-aging effects on the skin, specifically by decreasing the number and depths of wrinkles while increasing the elasticity and hydration of the skin.
For more information on this, click
here.
Devonian was in the news recently when the Company’s Board of Directors
approved the purchase subordinate voting shares in the capital of the corporation, exercisable at $1.20.
FULL DISCLOSURE: Devonian Health Group Inc. is a paid client of Stockhouse Publishing.